CD163 and colitis: In response to PNU-282987 treatment, we detected a significantly decreased number of CD68+M1 macrophages compared with the colitis model group, while the number of CD68+CD163+ M2 macrophages did not change, and the overall ratio of M1/M2 macrophages decreased significantly (Fig. 8A and B).